Literature DB >> 1721395

New onset of diabetes in FK 506 vs cyclosporine-treated kidney transplant recipients.

V Scantlebury1, R Shapiro, J Fung, A Tzakis, J McCauley, M Jordan, C Jensen, T Hakala, R Simmons, T E Starzl.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1721395      PMCID： PMC2977519     

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  2 in total

1.  Kidney transplantation under FK 506.

Authors:  T E Starzl; J Fung; M Jordan; R Shapiro; A Tzakis; J McCauley; J Johnston; Y Iwaki; A Jain; M Alessiani
Journal:  JAMA       Date:  1990-07-04       Impact factor: 56.272

2.  Steroid diabetes--a sign of overtreatment with steroids in the renal graft recipient?

Authors:  R Gunnarsson; G Lundgren; G Magnusson; L Ost; C G Groth
Journal:  Scand J Urol Nephrol Suppl       Date:  1980
  2 in total
  26 in total

Review 1.  Dysglycemia after renal transplantation: Definition, pathogenesis, outcomes and implications for management.

Authors:  David Langsford; Karen Dwyer
Journal:  World J Diabetes       Date:  2015-08-25

2.  A prospective, randomized trial of FK 506/prednisone vs FK 506/azathioprine/prednisone in renal transplant patients.

Authors:  R Shapiro; M L Jordan; V P Scantlebury; C Vivas; J J Fung; J McCauley; P Randhawa; A J Demetris; W Irish; A Jain
Journal:  Transplant Proc       Date:  1995-02       Impact factor: 1.066

3.  Posttransplant diabetes mellitus in African Americans after renal transplantation under FK 506 immunosuppression.

Authors:  O Odocha; J McCauley; V Scantlebury; R Shapiro; P Carroll; M Jordan; C Vivas; J J Fung; T E Starzl
Journal:  Transplant Proc       Date:  1993-08       Impact factor: 1.066

4.  Serum cholesterol levels in African Americans after renal transplantation under FK 506 immunosuppression.

Authors:  O Odocha; J McCauley; V Scantlebury; R Shapiro; P Carroll; M Jordan; C Vivas; J J Fung; T E Starzl
Journal:  Transplant Proc       Date:  1993-08       Impact factor: 1.066

5.  Long-term insulin requirement after liver transplantation with FK 506 in American veterans.

Authors:  J Tabasco-Minguillan; L Mieles; P Carroll; J Gavaler; D H Van Thiel; T E Starzl
Journal:  Transplant Proc       Date:  1993-02       Impact factor: 1.066

6.  Reversibility of tacrolimus-induced posttransplant diabetes: an illustrative case and review of the literature.

Authors:  R Shapiro; V P Scantlebury; M L Jordan; C Vivas; H A Gritsch; J McCauley; J J Fung; T R Hakala; R L Simmons; T E Starzl
Journal:  Transplant Proc       Date:  1997-09       Impact factor: 1.066

7.  Clinical features of acute reversible tacrolimus (FK 506) nephrotoxicity in kidney transplant recipients.

Authors:  S R Katari; M Magnone; R Shapiro; M Jordan; V Scantlebury; C Vivas; A Gritsch; J McCauley; T Starzl; A J Demetris; P S Randhawa
Journal:  Clin Transplant       Date:  1997-06       Impact factor: 2.863

8.  Tacrolimus versus cyclosporin for immunosuppression in renal transplantation: meta-analysis of randomised trials.

Authors:  G A Knoll; R C Bell
Journal:  BMJ       Date:  1999-04-24

9.  Renal transplantation at the University of Pittsburgh: the impact of FK506.

Authors:  R Shapiro; M Jordan; V P Scantlebury; C Vivas; H A Gritsch; A S Rao; M Trucco; A Zeevi; A J Demetris; P Randhawa
Journal:  Clin Transpl       Date:  1994

Review 10.  Clinical islet cell transplantation. Are we there yet?

Authors:  L Rosenberg
Journal:  Int J Pancreatol       Date:  1998-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.